Vol.4, No 1, 1997 pp. 17 - 22
UC 578.083
EFFECT OF PYRIDOXINE ON THE ALKALINE RIBONUCLEASE ACTIVITY IN THE LIVER OF DEXAMETHASONE TREATED RATS
Gordana Bjelaković, Dušica Pavlović, Jelenka Nikolić,Gordana Kocić, Bojana Stanković, Bojko Bjelaković
Institute of Biochemistry, Faculty of Medicine, Niš, Serbia, Yugoslavia 
Summary. Alkaline ribonuclease activity (pH 7.8) is present in most mammalian cells in both the free form and bound to an inhibitor protein.
It has been recently suggested that pyridoxal-5-phosphate interacts with ?-amino groups of lysine in human pancreatic ribonuclease. There is evidence that the nuclear binding of glucocorticoid-receptor complex can be inhibited by pyridoxal phosphate.
The data presented here suggest that treatment of experimental animals with dexamethasone during a 7- day period causes a decrease of alkaline RNase activities (total, free and latent RNases). In "in vitro" experimental condition dexamethasone also decreases total and latent RNase activity, but increase the free enzyme activity.
Pyridoxine/or pyridoxal phosphate in experiments in vivo or in vitro increases the free alkaline ribonuclease activity; pyridoxine/or pyridoxal phosphate decreases inhibitor-bound activity.
In the "in vivo" experimental condition vitamin B6 don?t modulates the effect of dexamethasone but in "in vitro" experiments the effects of dexamethasone are modulated by B6P ..
Key words: Alkaline ribonuclease, dexamethasone, pyridoxine, pyridoxal phosphate, rat liver
UTICAJ PIRIDOKSINA NA AKTIVNOST ALKALNE RIBONUKLEAZE JETRE PACOVA TRETIRANIH DEKSAMETAZONOM
Kratak sadržaj. Aktivnost alkalne ribonukleaze (pH 7,8) prisutna je u brojnim ćelijama sisara u slobodnom obliku ili u spoju sa  specifičnim inhibitornim proteinom.
Nedavno je dokazano da piridoksal-5-fosfat, aktivna forma piridoksina, interreaguje sa ?-amino grupama lizina u humanoj pankreasnoj ribonukleazi. Istovremeno postoje dokazi da nuklearno vezivanje glukokortikoid-receptor kompleksa može da se inhibiše piridoksal fosfatom.
Rezultati prikazani u našem radu ukazuju da tretiranje eksperimentalnih životinja deksametazonom u trajanju od 7 dana izaziva smanjenje aktivnosti alkalne ribonukleaze (ukupne,slobodne i latentne) u jetri pacova. U "in vitro" eksperimentalnim uslovima deksametazon takođe smanjuje aktivnost totalne i latentne alkalne ribonukleaze, ali povećava slobodnu aktivnost enzima.
Piridoksin/ili piridoksal fosfat u "in vivo" ili "in vitro" eksperimentalnim uslovima povećava aktivnost slobodne alkalne ribonukleaze; piridoksin /ili piridoksal fosfat smanjuju inhibitorom-vezanu aktivnost,latentnu ribonukleazu.
U ekspeimentima "in vivo" vitamin B6 ne dovodi do promene efekata deksametazona, ali u uslovima "in vitro" B6P modulira efekte deksametazona.
Ključne reči: Alkalna ribonukleaza, deksametazon, piridoksin, piridoksal fosfat, jetra pacova